Smallpox Vaccine
Progressive vaccinia more likely in patients with cell-mediated immunodeficiency
Published in Vaccine Weekly, April 30th, 2003
"The resumption of smallpox vaccination for health care workers and other first responders has raised concern about the occurrence of complications in people with immunodeficiency disorders, including those infected with human immunodeficiency virus. During the era of universal vaccination, roughly one person per million vaccinees in the general population developed progressive vaccinia, which is characterized by the relentless outward spread of infection from the vaccination site and eventual dissemination to other areas on the body,"...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2003-04-30)
More Articles from Vaccine Weekly
- Anthrax
Venezuelan equine encephalitis virus used as vector in anthrax vaccine - Hepatitis B Vaccine
Hepatitis B vaccination program a resounding success in Taiwan - Influenza Vaccine
Novel liposomal influenza subunit vaccine safe and effective in young adults - Pediatric Vaccine
Childhood vaccines do not cause allergic or autoimmune disease - Type 1 Diabetes
Inactivated coxsackievirus vaccine prevents onset of type 1 diabetes in mice - AIDS Vaccine
Recombinant adeno-associated virus (rAAV)-based HIV vaccine shows promise - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
